{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T07:40:03Z","timestamp":1750664403920,"version":"3.41.0"},"reference-count":39,"publisher":"Begell House","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Crit Rev Oncog"],"published-print":{"date-parts":[[2025]]},"abstract":"<p>Acute lymphoblastic leukemia (ALL) is a common pediatric cancer marked by uncontrolled proliferation of lymphoblasts, primarily affecting children aged two to five years. While treatment success rates have reached 90&amp;#37; in children, challenges such as therapy toxicity and relapse persist. The gut microbiome, known to impact immune function, is often disrupted in ALL patients, potentially worsening with treatments like chemotherapy and antibiotics. Research suggests probiotics may help restore microbial balance and mitigate side effects, with certain strains showing promise in reducing gastrointestinal symptoms; however, their use requires caution in immunocompromised patients due to infection risks. Probiotics could improve treatment outcomes in ALL, but further research is needed to establish safe, standardized protocols for use in this sensitive population.\n<\/p>","DOI":"10.1615\/critrevoncog.2025058176","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T16:41:46Z","timestamp":1738341706000},"page":"13-21","source":"Crossref","is-referenced-by-count":0,"title":["Review Article: Involvement of the Gut Microbiome and Probiotic Interventions in Pediatric Acute Lymphoblastic Leukemia"],"prefix":"10.1615","volume":"30","author":[{"given":"Inesa","family":"Navasardyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"613","reference":[{"key":"2","doi-asserted-by":"crossref","unstructured":"Bjork-Eriksson T, Bostrom M, Bryngelsson IL, Lahteenmaki PM, Jarfelt M, Kalm M, Olsson DS. Mortality among pediatric patients with acute lymphoblastic leukemia in sweden from 1988 to 2017. JAMA Netw Open. 2022;5(11):e2243857.","DOI":"10.1001\/jamanetworkopen.2022.43857"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Garniasih D, Susanah S, Sribudiani Y, Hilmanto D. The incidence and mortality of childhood acute lymphoblastic leukemia in Indonesia: A systematic review and meta-analysis. PLoS One. 2022;17(6):e0269706.","DOI":"10.1371\/journal.pone.0269706"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: A comprehensive review and 2017 update. Blood Cancer J. 2017;7(6):e577.","DOI":"10.1038\/bcj.2017.53"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Neaga A, Jimbu L, Mesaros O, Bota M, Lazar D, Cainap S, Blag C, Zdrenghea M. Why do children with acute lymphoblastic leukemia fare better than adults? Cancers. 2021;13(15):3886.","DOI":"10.3390\/cancers13153886"},{"key":"6","unstructured":"PDQ Pediatric Treatment Editorial Board. Childhood Acute Lymphoblastic Leukemia (PDQ): Patient Version. 2024 Nov 7. In: PDQ Cancer Information Summaries [Internet]. Bethesda, MD: National Cancer Institute (US); 2002."},{"key":"7","doi-asserted-by":"crossref","unstructured":"Stary J, Hrusak O. Recent advances in the management of pediatric acute lymphoblastic leukemia. F1000Research. 2016;5:2635.","DOI":"10.12688\/f1000research.9548.1"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Gilbert JA, Blaser MJ, Caporaso JG, Jansson JK, Lynch SV, Knight R. Current understanding of the human microbiome. Nat Med. 2018;24(4):392-400.","DOI":"10.1038\/nm.4517"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Greaves M. A causal mechanism for childhood acute lymphoblastic leukaemia. Nat Rev Cancer. 2018;18(8):471-84.","DOI":"10.1038\/s41568-018-0015-6"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Bhuta R, Nieder M, Jubelirer T, Ladas EJ. The gut microbiome and pediatric cancer: Current research and gaps in knowledge. J Natl Cancer Inst Monogr. 2019;2019(54):169-73.","DOI":"10.1093\/jncimonographs\/lgz026"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Rotz SJ, Dandoy CE. The microbiome in pediatric oncology. Cancer. 2020;126(16):3629-37.","DOI":"10.1002\/cncr.33030"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Wang X, Zhang P, Zhang X. Probiotics regulate gut microbiota: An effective method to improve immunity. Molecules. 2021;26(19):6076.","DOI":"10.3390\/molecules26196076"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Farhadi Rad H, Tahmasebi H, Javani S, Hemati M, Zakerhamidi D, Hosseini M, Alibabaei F, Banihashemian SZ, Oksenych V, Eslami M. Microbiota and cytokine modulation: Innovations in enhancing anticancer immunity and personalized cancer therapies. Biomedicines. 2024;12(12):2776.","DOI":"10.3390\/biomedicines12122776"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Yang L, Wang Q, He L, Sun X. The critical role of tumor microbiome in cancer immunotherapy. Cancer Biol Ther. 2024;25(1):2301801.","DOI":"10.1080\/15384047.2024.2301801"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Lehouritis P, Cummins J, Stanton M, Murphy CT, McCarthy FO, Reid G, Urbaniak C, Byrne WL, Tangney M. Local bacteria affect the efficacy of chemotherapeutic drugs. Sci Rep. 2015;5:14554.","DOI":"10.1038\/srep14554"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Geller LT, Barzily-Rokni M, Danino T, Jonas OH, Shental N, Nejman D, Gavert N, Zwang Y, Cooper ZA, Shee K, Thaiss CA, Reuben A, Livny J, Avraham R, Frederick DT, Ligorio M, Chatman K, Johnston SE, Mosher CM, Brandis A, Fuks G, Gurbatri C, Gopalakrishnan V, Kim M, Hurd MW, Katz M, Fleming J, Maitra A, Smith DA, Skalak M, Bu J, Michaud M, Trauger SA, Barshack I, Golan T, Sandbank J, Flaherty KT, Mandinova A, Garrett WS, Thayer SP, Ferrone CR, Huttenhower C, Bhatia SN, Gevers D, Wargo JA, Golub TR, Straussman R. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science. 2017;357(6356):1156-60.","DOI":"10.1126\/science.aah5043"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Sheflin AM, Whitney AK, Weir TL. Cancer-promoting effects of microbial dysbiosis. Curr Oncol Rep. 2014;16(10):406.","DOI":"10.1007\/s11912-014-0406-0"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Rodriguez-Hernandez G, Hauer J, Martin-Lorenzo A, Schafer D, Bartenhagen C, Garcia-Ramirez I, Auer F, Gonzalez-Herrero I, Ruiz-Roca L, Gombert M, Okpanyi V, Fischer U, Chen C, Dugas M, Bhatia S, Linka RM, Garcia-Suquia M, Rascon-Trincado MV, Garcia-Sanchez A, Blanco O, Garcia-Cenador MB, Garcia-Criado FJ, Cobaleda C, Alonso-Lopez D, De Las Rivas J, Muschen M, Vicente-Duenas C, Sanchez-Garcia I, Borkhardt A. Infection exposure promotes ETV6-RUNX1 precursor B-cell leukemia via impaired H3K4 demethylases. Cancer Res. 2017;77(16):4365-77.","DOI":"10.1158\/0008-5472.CAN-17-0701"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Vicente-Duenas C, Janssen S, Oldenburg M, Auer F, Gonzalez-Herrero I, Casado-Garcia A, Isidro-Hernandez M, Raboso-Gallego J, Westhoff P, Pandyra AA, Hein D, Gossling KL, Alonso-Lopez D, De Las Rivas J, Bhatia S, Garcia-Criado FJ, Garcia-Cenador MB, Weber APM, Kohrer K, Hauer J, Fischer U, Sanchez-Garcia I, Borkhardt A. An intact gut microbiome protects genetically predisposed mice against leukemia. Blood. 2020;136(18):2003-17.","DOI":"10.1182\/blood.2019004381"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Liu X, Zou Y, Zhang Y, Liu L, Duan Y, Zhang A, Zhang X, Zhang R, Zhao B, Li X, Wei T, He H, Gan Y, Wang K, Zhu X. Characteristics in gut microbiome is associated with chemotherapy-induced pneumonia in pediatric acute lymphoblastic leukemia. BMC Cancer. 2021;21(1): 1190.","DOI":"10.1186\/s12885-021-08917-y"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Bai L, Zhou P, Li D, Ju X. Changes in the gastrointestinal microbiota of children with acute lymphoblastic leukemia and its association with antibiotics in the short term. J Med Microbiol. 2017;66(9):1297-307.","DOI":"10.1099\/jmm.0.000568"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Thomas R, Wong WSW, Saadon R, Vilboux T, Deeken J, Niederhuber J, Hourigan SK, Yang E. Gut microbial composition difference between pediatric ALL survivors and siblings. Pediatr Hematol Oncol. 2020;37(6): 475-88.","DOI":"10.1080\/08880018.2020.1759740"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Chua LL, Rajasuriar R, Lim YAL, Woo YL, Loke P, Ariffin H. Temporal changes in gut microbiota profile in children with acute lymphoblastic leukemia prior to commencement-, during-, and post-cessation of chemotherapy. BMC Cancer. 2020;20(1):151.","DOI":"10.1186\/s12885-020-6654-5"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Peppas I, Ford AM, Furness CL, Greaves MF. Gut microbiome immaturity and childhood acute lymphoblastic leukaemia. Nat Rev Cancer. 2023;23(8):565-76.","DOI":"10.1038\/s41568-023-00584-4"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Liu X, Zou Y, Ruan M, Chang L, Chen X, Wang S, Yang W, Zhang L, Guo Y, Chen Y, Zhang Y, He H, Gan Y, Wang K, Zhu X. Pediatric acute lymphoblastic leukemia patients exhibit distinctive alterations in the gut microbiota. Front Cell Infect Microbiol. 2020;10:558799.","DOI":"10.3389\/fcimb.2020.558799"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Rajagopala SV, Singh H, Yu Y, Zabokrtsky KB, Torralba MG, Moncera KJ, Frank B, Pieper R, Sender L, Nelson KE. Persistent gut microbial dysbiosis in children with acute lymphoblastic leukemia (ALL) during chemotherapy. Microb Ecol. 2020;79(4):1034-43.","DOI":"10.1007\/s00248-019-01448-x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Masetti R, Muratore E, Leardini D, Zama D, Turroni S, Brigidi P, Esposito S, Pession A. Gut microbiome in pediatric acute leukemia: From predisposition to cure. Blood Adv. 2021;5(22):4619-29.","DOI":"10.1182\/bloodadvances.2021005129"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Hakim H, Dallas R, Wolf J, Tang L, Schultz-Cherry S, Darling V, Johnson C, Karlsson EA, Chang TC, Jeha S, Pui CH, Sun Y, Pounds S, Hayden RT, Tuomanen E, Rosch JW. Gut microbiome composition predicts infection risk during chemotherapy in children with acute lymphoblastic leukemia. Clin Infect Dis. 2018;67(4):541-8.","DOI":"10.1093\/cid\/ciy153"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Logan AC. Measurable residual disease in acute lympho-blastic leukemia: How low is low enough? Best Pract Res Clin Haematol. 2022;35(4):101407.","DOI":"10.1016\/j.beha.2022.101407"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Shah UA, Maclachlan KH, Derkach A, Salcedo M, Barnett K, Caple J, Blaslov J, Tran L, Ciardiello A, Burge M, Shekarkhand T, Adintori P, Cross J, Pianko MJ, Hosszu K, McAvoy D, Mailankody S, Korde N, Hultcrantz M, Hassoun H, Tan CR, Lu SX, Patel D, Diamond B, Shah G, Scordo M, Lahoud O, Chung DJ, Landau H, Usmani SZ, Giralt S, Taur Y, Landgren CO, Block G, Block T, Peled JU, van den Brink MRM, Lesokhin AM. Sustained minimal residual disease negativity in multiple myeloma is associated with stool butyrate and healthier plant-based diets. Clin Cancer Res. 2022;28(23):5149-55.","DOI":"10.1158\/1078-0432.CCR-22-0723"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Wang H, Zhang Y, Zhou Q, Yu L, Fu J, Lin D, Huang L, Lai X, Wu L, Zhang J, Zi J, Liao X, Huang S, Xie Y, He Y, Yang L. Microbial metagenomic shifts in children with acute lymphoblastic leukaemia during induction therapy and predictive biomarkers for infection. Ann Clin Microbiol Antimicrob. 2024;23(1):52.","DOI":"10.1186\/s12941-024-00717-z"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Mazziotta C, Tognon M, Martini F, Torreggiani E, Rotondo JC. Probiotics mechanism of action on immune cells and beneficial effects on human health. Cells. 2023;12(1): 184.","DOI":"10.3390\/cells12010184"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Badgeley A, Anwar H, Modi K, Murphy P, Lakshmikuttyamma A. Effect of probiotics and gut microbiota on anti-cancer drugs: Mechanistic perspectives. Biochim Biophys Acta Rev Cancer. 2021;1875(1):188494.","DOI":"10.1016\/j.bbcan.2020.188494"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Zhou P, Chen C, Patil S, Dong S. Unveiling the therapeutic symphony of probiotics, prebiotics, and postbiotics in gut-immune harmony. Front Nutr. 2024;11:1355542.","DOI":"10.3389\/fnut.2024.1355542"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Hrdy J, Alard J, Couturier-Maillard A, Boulard O, Boutillier D, Delacre M, Lapadatescu C, Cesaro A, Blanc P, Pot B, Ryffel B, Chamaillard M, Grangette C. Lactobacillus reuteri 5454 and Bifidobacterium animalis ssp. lactis 5764 improve colitis while differentially impacting dendritic cells maturation and antimicrobial responses. Sci Rep. 2020;10(1):5345.","DOI":"10.1038\/s41598-020-62161-1"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Nagao-Kitamoto H, Leslie JL, Kitamoto S, Jin C, Thomsson KA, Gillilland MG 3rd, Kuffa P, Goto Y, Jenq RR, Ishii C, Hirayama A, Seekatz AM, Martens EC, Eaton KA, Kao JY, Fukuda S, Higgins PDR, Karlsson NG, Young VB, Kamada N. Interleukin-22-mediated host glycosylation prevents Clostridioides difficile infection by modulating the metabolic activity of the gut microbiota. Nat Med. 2020;26(4):608-17.","DOI":"10.1038\/s41591-020-0764-0"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Deleemans JM, Gajtani Z, Baydoun M, Reimer RA, Piedalue KA, Carlson LE. The use of prebiotic and probiotic interventions for treating gastrointestinal and psychosocial health symptoms in cancer patients and survivors: A systematic review. Integr Cancer Ther. 2021;20:15347354211061733.","DOI":"10.1177\/15347354211061733"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Reyna-Figueroa J, Barron-Calvillo E, Garcia-Parra C, Galindo-Delgado P, Contreras-Ochoa C, Lagunas-Martinez A, Campos-Romero FH, Silva-Estrada JA, Limon-Rojas AE. Probiotic supplementation decreases chemotherapy-induced gastrointestinal side effects in patients with acute leukemia. J Pediatr Hematol Oncol. 2019;41(6):468-72.","DOI":"10.1097\/MPH.0000000000001497"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Bielik V, Hric I, Smahova S, Tkacikova M, Hlavacova V, Nechalova L, Ugrayova S, Kolenova A. The effect of physical exercise and dairy probiotics (Lactobacillus casei) on gut microbiome in childhood cancer survivors. Neoplasma. 2023;70(4):588-96.","DOI":"10.4149\/neo_2023_230526N287"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Avcin SL, Pokorn M, Kitanovski L, Premru MM, Jazbec J. Bifidobacterium breve sepsis in child with highrisk acute lymphoblastic leukemia. Emerg Infect Dis. 2015;21(9):1674-5.","DOI":"10.3201\/eid2109.150097"}],"container-title":["Critical Reviews\u2122 in Oncogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dl.begellhouse.com\/download\/article\/2332743e4b071b83\/CRO-58176.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T07:02:35Z","timestamp":1750662155000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dl.begellhouse.com\/journals\/439f422d0783386a,09eb0aa2691d05f5,2332743e4b071b83.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1615\/critrevoncog.2025058176","relation":{},"ISSN":["0893-9675"],"issn-type":[{"type":"print","value":"0893-9675"}],"subject":[],"published":{"date-parts":[[2025]]}}}